0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Endocrine Disruptor Testing Market Research Report 2026
Published Date: 2026-01-19
|
Report Code: QYRE-Auto-12C18748
Home | Market Reports | Health
Global Endocrine Disruptor Testing Market Research Report 2024
BUY CHAPTERS

Global Endocrine Disruptor Testing Market Research Report 2026

Code: QYRE-Auto-12C18748
Report
2026-01-19
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Endocrine Disruptor Testing Market Size

The global Endocrine Disruptor Testing market was valued at US$ 213 million in 2025 and is anticipated to reach US$ 368 million by 2032, at a CAGR of 8.3% from 2026 to 2032.

Endocrine Disruptor Testing Market

Endocrine Disruptor Testing Market

Endocrine Disruptor Testing refers to the process of evaluating substances to determine their potential to interfere with the endocrine (hormonal) system in humans and animals. These tests assess whether chemicals can mimic, block, or alter hormone functions, which can lead to adverse health effects such as developmental, reproductive, neurological, or immune system disruptions. The testing typically involves in vitro (cell-based), in vivo (animal), and computational models to identify endocrine activity, and is crucial for regulatory agencies to assess the safety of chemicals in pharmaceuticals, pesticides, and other consumer products.
The North American market for Endocrine Disruptor Testing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Endocrine Disruptor Testing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Endocrine Disruptor Testing in Environmental Monitoring is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Endocrine Disruptor Testing include Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, Smithers, LAUS, Xenometrix, ToxStrategies, Fera Science, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Endocrine Disruptor Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Endocrine Disruptor Testing. The Endocrine Disruptor Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Endocrine Disruptor Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Endocrine Disruptor Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Endocrine Disruptor Testing Market Report

Report Metric Details
Report Name Endocrine Disruptor Testing Market
Accounted market size in 2025 US$ 213 million
Forecasted market size in 2032 US$ 368 million
CAGR 8.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • In Vitro (Cell-based) Testing
  • In Vivo (Animal) Testing
  • In Silico (Computational) Modeling
  • Others
Segment by Application
  • Environmental Monitoring
  • Food Safety
  • Cosmetics and Personal Care Products
  • Public Health and Disease Prevention
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, Smithers, LAUS, Xenometrix, ToxStrategies, Fera Science, Compliance Services International, Staphyt, Creative Proteomics, Creative Bioarray
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Endocrine Disruptor Testing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Endocrine Disruptor Testing Market growing?

Ans: The Endocrine Disruptor Testing Market witnessing a CAGR of 8.3% during the forecast period 2026-2032.

What is the Endocrine Disruptor Testing Market size in 2032?

Ans: The Endocrine Disruptor Testing Market size in 2032 will be US$ 368 million.

Who are the main players in the Endocrine Disruptor Testing Market report?

Ans: The main players in the Endocrine Disruptor Testing Market are Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, Smithers, LAUS, Xenometrix, ToxStrategies, Fera Science, Compliance Services International, Staphyt, Creative Proteomics, Creative Bioarray

What are the Application segmentation covered in the Endocrine Disruptor Testing Market report?

Ans: The Applications covered in the Endocrine Disruptor Testing Market report are Environmental Monitoring, Food Safety, Cosmetics and Personal Care Products, Public Health and Disease Prevention, Others

What are the Type segmentation covered in the Endocrine Disruptor Testing Market report?

Ans: The Types covered in the Endocrine Disruptor Testing Market report are In Vitro (Cell-based) Testing, In Vivo (Animal) Testing, In Silico (Computational) Modeling, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruptor Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vitro (Cell-based) Testing
1.2.3 In Vivo (Animal) Testing
1.2.4 In Silico (Computational) Modeling
1.2.5 Others
1.3 Market by Application
1.3.1 Global Endocrine Disruptor Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Environmental Monitoring
1.3.3 Food Safety
1.3.4 Cosmetics and Personal Care Products
1.3.5 Public Health and Disease Prevention
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruptor Testing Market Perspective (2021–2032)
2.2 Global Endocrine Disruptor Testing Growth Trends by Region
2.2.1 Global Endocrine Disruptor Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Endocrine Disruptor Testing Historic Market Size by Region (2021–2026)
2.2.3 Endocrine Disruptor Testing Forecasted Market Size by Region (2027–2032)
2.3 Endocrine Disruptor Testing Market Dynamics
2.3.1 Endocrine Disruptor Testing Industry Trends
2.3.2 Endocrine Disruptor Testing Market Drivers
2.3.3 Endocrine Disruptor Testing Market Challenges
2.3.4 Endocrine Disruptor Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruptor Testing Players by Revenue
3.1.1 Global Top Endocrine Disruptor Testing Players by Revenue (2021–2026)
3.1.2 Global Endocrine Disruptor Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Endocrine Disruptor Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Endocrine Disruptor Testing Revenue
3.4 Global Endocrine Disruptor Testing Market Concentration Ratio
3.4.1 Global Endocrine Disruptor Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruptor Testing Revenue in 2025
3.5 Global Key Players of Endocrine Disruptor Testing Head Offices and Areas Served
3.6 Global Key Players of Endocrine Disruptor Testing, Products and Applications
3.7 Global Key Players of Endocrine Disruptor Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Endocrine Disruptor Testing Breakdown Data by Type
4.1 Global Endocrine Disruptor Testing Historic Market Size by Type (2021–2026)
4.2 Global Endocrine Disruptor Testing Forecasted Market Size by Type (2027–2032)
5 Endocrine Disruptor Testing Breakdown Data by Application
5.1 Global Endocrine Disruptor Testing Historic Market Size by Application (2021–2026)
5.2 Global Endocrine Disruptor Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Endocrine Disruptor Testing Market Size (2021–2032)
6.2 North America Endocrine Disruptor Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Endocrine Disruptor Testing Market Size by Country (2021–2026)
6.4 North America Endocrine Disruptor Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrine Disruptor Testing Market Size (2021–2032)
7.2 Europe Endocrine Disruptor Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Endocrine Disruptor Testing Market Size by Country (2021–2026)
7.4 Europe Endocrine Disruptor Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruptor Testing Market Size (2021–2032)
8.2 Asia-Pacific Endocrine Disruptor Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Endocrine Disruptor Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Endocrine Disruptor Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Endocrine Disruptor Testing Market Size (2021–2032)
9.2 Latin America Endocrine Disruptor Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Endocrine Disruptor Testing Market Size by Country (2021–2026)
9.4 Latin America Endocrine Disruptor Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruptor Testing Market Size (2021–2032)
10.2 Middle East & Africa Endocrine Disruptor Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Endocrine Disruptor Testing Introduction
11.1.4 Charles River Laboratories Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.1.5 Charles River Laboratories Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Endocrine Disruptor Testing Introduction
11.2.4 Labcorp Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.2.5 Labcorp Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Endocrine Disruptor Testing Introduction
11.3.4 Eurofins Scientific Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.3.5 Eurofins Scientific Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Details
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Endocrine Disruptor Testing Introduction
11.4.4 PerkinElmer Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.4.5 PerkinElmer Recent Development
11.5 Intertek
11.5.1 Intertek Company Details
11.5.2 Intertek Business Overview
11.5.3 Intertek Endocrine Disruptor Testing Introduction
11.5.4 Intertek Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.5.5 Intertek Recent Development
11.6 Smithers
11.6.1 Smithers Company Details
11.6.2 Smithers Business Overview
11.6.3 Smithers Endocrine Disruptor Testing Introduction
11.6.4 Smithers Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.6.5 Smithers Recent Development
11.7 LAUS
11.7.1 LAUS Company Details
11.7.2 LAUS Business Overview
11.7.3 LAUS Endocrine Disruptor Testing Introduction
11.7.4 LAUS Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.7.5 LAUS Recent Development
11.8 Xenometrix
11.8.1 Xenometrix Company Details
11.8.2 Xenometrix Business Overview
11.8.3 Xenometrix Endocrine Disruptor Testing Introduction
11.8.4 Xenometrix Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.8.5 Xenometrix Recent Development
11.9 ToxStrategies
11.9.1 ToxStrategies Company Details
11.9.2 ToxStrategies Business Overview
11.9.3 ToxStrategies Endocrine Disruptor Testing Introduction
11.9.4 ToxStrategies Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.9.5 ToxStrategies Recent Development
11.10 Fera Science
11.10.1 Fera Science Company Details
11.10.2 Fera Science Business Overview
11.10.3 Fera Science Endocrine Disruptor Testing Introduction
11.10.4 Fera Science Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.10.5 Fera Science Recent Development
11.11 Compliance Services International
11.11.1 Compliance Services International Company Details
11.11.2 Compliance Services International Business Overview
11.11.3 Compliance Services International Endocrine Disruptor Testing Introduction
11.11.4 Compliance Services International Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.11.5 Compliance Services International Recent Development
11.12 Staphyt
11.12.1 Staphyt Company Details
11.12.2 Staphyt Business Overview
11.12.3 Staphyt Endocrine Disruptor Testing Introduction
11.12.4 Staphyt Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.12.5 Staphyt Recent Development
11.13 Creative Proteomics
11.13.1 Creative Proteomics Company Details
11.13.2 Creative Proteomics Business Overview
11.13.3 Creative Proteomics Endocrine Disruptor Testing Introduction
11.13.4 Creative Proteomics Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.13.5 Creative Proteomics Recent Development
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Details
11.14.2 Creative Bioarray Business Overview
11.14.3 Creative Bioarray Endocrine Disruptor Testing Introduction
11.14.4 Creative Bioarray Revenue in Endocrine Disruptor Testing Business (2021–2026)
11.14.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Endocrine Disruptor Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of In Vitro (Cell-based) Testing
 Table 3. Key Players of In Vivo (Animal) Testing
 Table 4. Key Players of In Silico (Computational) Modeling
 Table 5. Key Players of Others
 Table 6. Global Endocrine Disruptor Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Endocrine Disruptor Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Endocrine Disruptor Testing Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Endocrine Disruptor Testing Market Share by Region (2021–2026)
 Table 10. Global Endocrine Disruptor Testing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Endocrine Disruptor Testing Market Share by Region (2027–2032)
 Table 12. Endocrine Disruptor Testing Market Trends
 Table 13. Endocrine Disruptor Testing Market Drivers
 Table 14. Endocrine Disruptor Testing Market Challenges
 Table 15. Endocrine Disruptor Testing Market Restraints
 Table 16. Global Endocrine Disruptor Testing Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Endocrine Disruptor Testing Market Share by Players (2021–2026)
 Table 18. Global Top Endocrine Disruptor Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Endocrine Disruptor Testing Revenue, 2025
 Table 19. Ranking of Global Top Endocrine Disruptor Testing Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Endocrine Disruptor Testing Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Endocrine Disruptor Testing, Headquarters and Area Served
 Table 22. Global Key Players of Endocrine Disruptor Testing, Products and Applications
 Table 23. Global Key Players of Endocrine Disruptor Testing, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Endocrine Disruptor Testing Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Endocrine Disruptor Testing Revenue Market Share by Type (2021–2026)
 Table 27. Global Endocrine Disruptor Testing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Endocrine Disruptor Testing Revenue Market Share by Type (2027–2032)
 Table 29. Global Endocrine Disruptor Testing Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Endocrine Disruptor Testing Revenue Market Share by Application (2021–2026)
 Table 31. Global Endocrine Disruptor Testing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Endocrine Disruptor Testing Revenue Market Share by Application (2027–2032)
 Table 33. North America Endocrine Disruptor Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Endocrine Disruptor Testing Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Endocrine Disruptor Testing Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Endocrine Disruptor Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Endocrine Disruptor Testing Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Endocrine Disruptor Testing Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Endocrine Disruptor Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Endocrine Disruptor Testing Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Endocrine Disruptor Testing Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Endocrine Disruptor Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Endocrine Disruptor Testing Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Endocrine Disruptor Testing Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Endocrine Disruptor Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Endocrine Disruptor Testing Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Endocrine Disruptor Testing Market Size by Country (US$ Million), 2027–2032
 Table 48. Charles River Laboratories Company Details
 Table 49. Charles River Laboratories Business Overview
 Table 50. Charles River Laboratories Endocrine Disruptor Testing Product
 Table 51. Charles River Laboratories Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 52. Charles River Laboratories Recent Development
 Table 53. Labcorp Company Details
 Table 54. Labcorp Business Overview
 Table 55. Labcorp Endocrine Disruptor Testing Product
 Table 56. Labcorp Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 57. Labcorp Recent Development
 Table 58. Eurofins Scientific Company Details
 Table 59. Eurofins Scientific Business Overview
 Table 60. Eurofins Scientific Endocrine Disruptor Testing Product
 Table 61. Eurofins Scientific Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 62. Eurofins Scientific Recent Development
 Table 63. PerkinElmer Company Details
 Table 64. PerkinElmer Business Overview
 Table 65. PerkinElmer Endocrine Disruptor Testing Product
 Table 66. PerkinElmer Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 67. PerkinElmer Recent Development
 Table 68. Intertek Company Details
 Table 69. Intertek Business Overview
 Table 70. Intertek Endocrine Disruptor Testing Product
 Table 71. Intertek Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 72. Intertek Recent Development
 Table 73. Smithers Company Details
 Table 74. Smithers Business Overview
 Table 75. Smithers Endocrine Disruptor Testing Product
 Table 76. Smithers Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 77. Smithers Recent Development
 Table 78. LAUS Company Details
 Table 79. LAUS Business Overview
 Table 80. LAUS Endocrine Disruptor Testing Product
 Table 81. LAUS Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 82. LAUS Recent Development
 Table 83. Xenometrix Company Details
 Table 84. Xenometrix Business Overview
 Table 85. Xenometrix Endocrine Disruptor Testing Product
 Table 86. Xenometrix Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 87. Xenometrix Recent Development
 Table 88. ToxStrategies Company Details
 Table 89. ToxStrategies Business Overview
 Table 90. ToxStrategies Endocrine Disruptor Testing Product
 Table 91. ToxStrategies Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 92. ToxStrategies Recent Development
 Table 93. Fera Science Company Details
 Table 94. Fera Science Business Overview
 Table 95. Fera Science Endocrine Disruptor Testing Product
 Table 96. Fera Science Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 97. Fera Science Recent Development
 Table 98. Compliance Services International Company Details
 Table 99. Compliance Services International Business Overview
 Table 100. Compliance Services International Endocrine Disruptor Testing Product
 Table 101. Compliance Services International Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 102. Compliance Services International Recent Development
 Table 103. Staphyt Company Details
 Table 104. Staphyt Business Overview
 Table 105. Staphyt Endocrine Disruptor Testing Product
 Table 106. Staphyt Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 107. Staphyt Recent Development
 Table 108. Creative Proteomics Company Details
 Table 109. Creative Proteomics Business Overview
 Table 110. Creative Proteomics Endocrine Disruptor Testing Product
 Table 111. Creative Proteomics Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 112. Creative Proteomics Recent Development
 Table 113. Creative Bioarray Company Details
 Table 114. Creative Bioarray Business Overview
 Table 115. Creative Bioarray Endocrine Disruptor Testing Product
 Table 116. Creative Bioarray Revenue in Endocrine Disruptor Testing Business (US$ Million), 2021–2026
 Table 117. Creative Bioarray Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Endocrine Disruptor Testing Picture
 Figure 2. Global Endocrine Disruptor Testing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Endocrine Disruptor Testing Market Share by Type: 2025 vs 2032
 Figure 4. In Vitro (Cell-based) Testing Features
 Figure 5. In Vivo (Animal) Testing Features
 Figure 6. In Silico (Computational) Modeling Features
 Figure 7. Others Features
 Figure 8. Global Endocrine Disruptor Testing Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Endocrine Disruptor Testing Market Share by Application: 2025 vs 2032
 Figure 10. Environmental Monitoring Case Studies
 Figure 11. Food Safety Case Studies
 Figure 12. Cosmetics and Personal Care Products Case Studies
 Figure 13. Public Health and Disease Prevention Case Studies
 Figure 14. Others Case Studies
 Figure 15. Endocrine Disruptor Testing Report Years Considered
 Figure 16. Global Endocrine Disruptor Testing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 17. Global Endocrine Disruptor Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Endocrine Disruptor Testing Market Share by Region: 2025 vs 2032
 Figure 19. Global Endocrine Disruptor Testing Market Share by Players in 2025
 Figure 20. Global Endocrine Disruptor Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 21. The Top 10 and 5 Players Market Share by Endocrine Disruptor Testing Revenue in 2025
 Figure 22. North America Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. North America Endocrine Disruptor Testing Market Share by Country (2021–2032)
 Figure 24. United States Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Canada Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe Endocrine Disruptor Testing Market Share by Country (2021–2032)
 Figure 28. Germany Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. France Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. U.K. Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Italy Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Russia Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Ireland Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific Endocrine Disruptor Testing Market Share by Region (2021–2032)
 Figure 36. China Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Japan Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. South Korea Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Southeast Asia Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. India Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Australia & New Zealand Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America Endocrine Disruptor Testing Market Share by Country (2021–2032)
 Figure 44. Mexico Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Brazil Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa Endocrine Disruptor Testing Market Share by Country (2021–2032)
 Figure 48. Israel Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. UAE Endocrine Disruptor Testing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Charles River Laboratories Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 52. Labcorp Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 53. Eurofins Scientific Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 54. PerkinElmer Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 55. Intertek Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 56. Smithers Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 57. LAUS Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 58. Xenometrix Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 59. ToxStrategies Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 60. Fera Science Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 61. Compliance Services International Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 62. Staphyt Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 63. Creative Proteomics Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 64. Creative Bioarray Revenue Growth Rate in Endocrine Disruptor Testing Business (2021–2026)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD